Company · CIK 0001821586
MoonLake Immunotherapeutics
MLTXSearch this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
Market data
Price
$12.56−$0.06 (−0.475%)
MLTX · Last trade
- Prev close
- $12.62
- Range (29d)
- $9.55 – $12.62
On the record
Recent filings
- 8-KMLTXCurrent report0001213900-26-105240 · 189.7 KBSEC(opens sec.gov)
- SCHEDULE 13G/AMLTXMoonLake Immunotherapeutics0001172661-26-003691 · 9.7 KBSEC(opens sec.gov)
- SCHEDULE 13GMLTXMoonLake Immunotherapeutics0001897612-26-000611 · 7.5 KBSEC(opens sec.gov)
- SCHEDULE 13G/AMLTXMoonLake Immunotherapeutics0001172661-26-003483 · 12.0 KBSEC(opens sec.gov)
- 10-QMLTXQuarterly update0001821586-26-000010 · 9.6 MBSEC(opens sec.gov)
- 8-KMLTXCurrent report0001213900-26-086939 · 320.9 KBSEC(opens sec.gov)
- 8-KMLTXCurrent report0001213900-26-078031 · 193.6 KBSEC(opens sec.gov)
- 8-KMLTXCurrent report0001213900-26-071721 · 807.6 KBSEC(opens sec.gov)
- 8-KMLTXCurrent report0001213900-26-070362 · 24.6 MBSEC(opens sec.gov)
- 8-KMLTXCurrent report0001213900-26-066821 · 350.5 KBSEC(opens sec.gov)
Insiders
- BIOTECHNOLOGY VALUE FUND L PDirector, 10% Owner
- Biotechnology Value Trading Fund OS LPDirector, See Explanation of Responses
- Bodenstedt MatthiasChief Financial Officer
- BVF GP HOLDINGS LLCDirector, 10% Owner
- BVF I GP LLCDirector, 10% Owner
- BVF II GP LLCDirector, See Explanation of Responses
- BVF INC/ILDirector, 10% Owner
- BVF PARTNERS L P/ILDirector, 10% Owner
- BVF Partners OS Ltd.Director, See Explanation of Responses
- CHANG NANCY TDirector
Tickers
Addresses
business
DORFSTRASSE 29
ZUG, V8, 6300
mailing
DORFSTRASSE 29
ZUG, V8, 6300
Former names
- Helix Acquisition Corp2022-03-31
Same industry